Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias ; volume:15 ; number:1 ; day:24 ; month:3 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of hematology & oncology ; 15, Heft 1 (24.3.2022), 1-21, 12.2022
- Urheber
-
Yi, Yan
Ge, Shenglei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-022-01251-1
- URN
-
urn:nbn:de:101:1-2022061521231852276158
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yi, Yan
- Ge, Shenglei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
The molecular function of MLL/AF4 for patient derived acute leukemias growing in mice
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
The molecular function of MLL/AF4 for patient derived acute leukemias growing in mice
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML